Shopping Cart
- Remove All
Your shopping cart is currently empty
GPRC5D Protein, Human, Recombinant, Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 38.80 kDa and the accession number is Q9NZD1-1.

| Pack Size | Price | Availability | Quantity |
|---|---|---|---|
| 5 μg | $298 | 7-10 days | |
| 10 μg | $490 | 7-10 days | |
| 20 μg | $838 | 7-10 days | |
| 50 μg | $1,230 | 7-10 days | |
| 100 μg | $1,930 | 7-10 days | |
| 200 μg | $2,750 | 7-10 days | |
| 500 μg | $6,150 | 7-10 days |
| Biological Activity | Immobilized Biotinylated Human GPRC5D-VLP (Full Length) Protein at 5 μg/mL (100 μL/well) on streptavidin precoated (2 μg/well) can bind Anti-Human GPRC5D Antibody, Human IgG1, the EC50 is 4-12ng/mL. |
| Description | GPRC5D Protein, Human, Recombinant, Biotinylated is expressed in HEK293 mammalian cells. The predicted molecular weight is 38.80 kDa and the accession number is Q9NZD1-1. |
| Species | Human |
| Expression System | HEK293 Cells |
| Tag | Tag Free |
| Accession Number | Q9NZD1-1 |
| Synonyms | GPRC5D |
| Construction | A DNA sequence encoding the human GPRC5D (Q9NZD1-1) (Met1-Val345) was expressed. Predicted N terminal: Met 1 |
| Molecular Weight | 38.80 kDa (predicted) |
| Endotoxin | < 1.0 EU/μg of the protein as determined by the LAL method. |
| Formulation | Supplied as sterile solution in 50 mM HEPES, 150 mM NaCI, 10% Trehalose, pH 7.2. |
| Stability & Storage | It is recommended to store the product under sterile conditions at -70°C or lower. Samples are stable for up to 12 months at -80°C. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
| Shipping | Shipping with blue ice. |
| Research Background | Orphan G-protein-coupled receptor family C group 5 member D (GPRC5D) has seven transmembrane segments forming the core of the receptor, as well as an intracellular C-tail and an extracellular N-terminal domain. GPRC5D is highly and selectively expressed on the surface of CD138+ multiple myeloma (MM) cells, whereas in normal tissues, a much lower expression is limited to plasma cells and certain hard keratinizing tissues. This makes GPRC5D a promising marker for monitoring tumor load and a target antigen for MM-specific T cell-engaging therapies such as bispecific antibodies and CAR-T cells. |

Copyright © 2015-2025 TargetMol Chemicals Inc. All Rights Reserved.